Although our NMR results showed that CB839 did not reduce the lactate levels in RAFLS, Zacharias et al. reported that obstruction of glutaminase activity by the action of CB839 has been shown to reduce the amount of lactate in AML (acute myeloid leukemia) [67]. The gene discussed is GLS; the disease is acute myeloid leukemia.